Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-25

Clinical Trial Update: Safety and Quality of Life of Three Treatment Strategies for Low-Risk Papillary Thyroid Microcarcinoma

View source ↗

Summary

This clinical trial from Xijing Hospital is evaluating safety and quality of life across three treatment strategies for low-risk papillary thyroid microcarcinom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Xijing Hospital | Conditions: Papillary Thyroid Microcarcinoma | Status: NOT_YET_RECRUITING